Showing results (301-310 of 472) with videos related to
Sort By:
Pageof 48
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1989
A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow supportT C Shea, M Flaherty, A Elias, et al.Leukemia & Lymphoma|August 5, 2011
A phase I study evaluating ibritumomab tiuxetan (Zevalin®) in combination with bortezomib (Velcade®) in relapsed/refractory mantle cell and low grade B-cell non-Hodgkin lymphomaAnne W Beaven, Thomas C Shea, Dominic T Moore, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2012
Bone marrow B cell precursor number after allogeneic stem cell transplantation and GVHD developmentYuri Fedoriw, T Danielle Samulski, Allison M Deal, et al.Cancer Research|November 15, 1989
Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistanceY Y Wang, B A Teicher, T C Shea, et al.Ground Water|April 19, 2016
Use of Nitrogen-15-Enriched Escherichia coli as a Bacterial Tracer in Karst AquifersJames W Ward, John G Warden, Ashley M Bandy, et al.Journal of Patient-Reported Outcomes|January 31, 2023
Qualitative interviews to evaluate content validity of the ACTIV-2 COVID-19 Symptom Diary (ACSD)Louis S Matza, Katie D Stewart, April N Naegeli, et al.BJU International|March 24, 2009
The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTSChris C Sexton, Karin S Coyne, Zoe S Kopp, et al.Journal of Cell Science|May 24, 2007
Identification of novel chromatin-associated proteins involved in programmed genome rearrangements in TetrahymenaMeng-Chao Yao, Ching-Ho Yao, Lia M Halasz, et al.Cancer Research|November 1, 1990
Glutathione transferase activity and isoenzyme composition in primary human breast cancersT C Shea, G Claflin, K E Comstock, et al.Cancer Chemotherapy and Pharmacology|January 1, 1991
A phase I trial of continuous-infusion cyclophosphamide in refractory cancer patientsJ P Eder, A D Elias, L Ayash, et al.Pageof 48